Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Profit from core business operations before interest and taxes
Latest
$55.43M
↑ 122% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
$-246.53M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $55.43M | +133.6% |
| 2024 | $-164.98M | +68.1% |
| 2023 | $-517.12M | +13.0% |
| 2022 | $-594.61M | -10.9% |
| 2021 | $-536.28M | -150.9% |
| 2020 | $-213.73M | +25.8% |
| 2019 | $-288.02M | -125.1% |
| 2018 | $-127.92M | -152.0% |
| 2017 | $-50.77M | -86.1% |
| 2016 | $-27.28M | - |